Renaissance Technologies’s Applied Therapeutics APLT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,706,156
| Closed | -$271K | – | 3237 |
|
|
2025
Q4 | $271K | Buy |
+2,706,156
| New | +$1.72M | ﹤0.01% | 2796 |
|
|
2024
Q2 | – | Sell |
-175,800
| Closed | -$1.2M | – | 3470 |
|
|
2024
Q1 | $1.2M | Sell |
175,800
-477,287
| -73% | -$2.14M | ﹤0.01% | 2378 |
|
|
2023
Q4 | $2.19M | Buy |
653,087
+237,609
| +57% | +$591K | ﹤0.01% | 1897 |
|
|
2023
Q3 | $1.03M | Buy |
415,478
+8,100
| +2% | +$13.4K | ﹤0.01% | 2270 |
|
|
2023
Q2 | $521K | Buy |
407,378
+187,578
| +85% | +$249K | ﹤0.01% | 2849 |
|
|
2023
Q1 | $178K | Sell |
219,800
-98,178
| -31% | -$96.7K | ﹤0.01% | 3326 |
|
|
2022
Q4 | $242K | Sell |
317,978
-16,311
| -5% | -$12.9K | ﹤0.01% | 3327 |
|
|
2022
Q3 | $311K | Buy |
334,289
+70,111
| +27% | +$84.1K | ﹤0.01% | 3193 |
|
|
2022
Q2 | $250K | Sell |
264,178
-18,022
| -6% | -$29.5K | ﹤0.01% | 3547 |
|
|
2022
Q1 | $595K | Buy |
282,200
+264,600
| +1,503% | +$709K | ﹤0.01% | 3078 |
|
|
2021
Q4 | $158K | Buy |
+17,600
| New | +$231K | ﹤0.01% | 3592 |
|
|
2020
Q2 | – | Sell |
-19,486
| Closed | -$637K | – | 3415 |
|
|
2020
Q1 | $637K | Buy |
+19,486
| New | +$788K | ﹤0.01% | 2646 |
|
Renaissance Technologies's APLT Position: Q1 2026 in Review
Renaissance Technologies sold out of Applied Therapeutics (APLT) in Q1 2026, closing a stake of 2,706,156 shares — an estimated $271K sold.
Renaissance Technologies first reported a position in APLT in Q1 2020 and held it in 12 quarters. The position peaked at $2.19M in Q4 2023. 0 funds tracked by Wall St. Rank hold APLT as of Q1 2026.
- Renaissance Technologies reported no remaining Applied Therapeutics position as of Q1 2026 after selling out during the quarter.
- Renaissance Technologies sold 2,706,156 Applied Therapeutics shares in Q1 2026, an estimated $271K.
- Renaissance Technologies first reported a position in Applied Therapeutics in Q1 2020 and held it in 12 quarters.
- Renaissance Technologies's Applied Therapeutics position peaked at $2.19M in Q4 2023.
- 0 funds tracked by Wall St. Rank held Applied Therapeutics as of Q1 2026.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.